Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (41-50 of 740) with videos related to

Pageof 74
Sort By:
The Lancet. Haematology|October 7, 2018
Thalidomide for myeloma: still here?Meletios A Dimopoulos, Efstathios Kastritis
Nature Reviews. Clinical Oncology|November 28, 2009
Hematology: first-line bortezomib benefits patients with multiple myelomaMeletios A Dimopoulos, Evangelos Terpos
The American Journal of Medicine|October 7, 2004
Adverse effects of thalidomide administration in patients with neoplastic diseasesMeletios A Dimopoulos, Vagelis Eleutherakis-Papaiakovou
The Lancet. Oncology|January 6, 2018
Carfilzomib for relapsed or refractory multiple myeloma - Authors' replyMeletios A Dimopoulos, Amy S Kimball
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Reply to S. Al Hadidi et alMeletios A Dimopoulos, Jesús San-Miguel
Seminars in Hematology|April 25, 2009
Treatment of relapsed/refractory multiple myelomaEfstathios Kastritis, Antonio Palumbo, Meletios A Dimopoulos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Treatment of plasma cell dyscrasias with thalidomide and its derivativesMeletios A Dimopoulos, Athanasios Anagnostopoulos, Donna Weber
The New England Journal of Medicine|November 15, 2018
Ibrutinib and Rituximab in Waldenström's MacroglobulinemiaMeletios A Dimopoulos, Zeena Salman, Christian Buske
Advances in Chronic Kidney Disease|August 28, 2012
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspectiveEsftathios Kastritis, Meletios A Dimopoulos, Joan Bladé
Expert Opinion on Pharmacotherapy|May 28, 2013
Current treatments for renal failure due to multiple myelomaEfstathios Kastritis, Evangelos Terpos, Meletios A Dimopoulos
Pageof 74

Showing results (41-50 of 740) with videos related to

Sort By:
Pageof 74
The Lancet. Haematology|October 7, 2018
Thalidomide for myeloma: still here?Meletios A Dimopoulos, Efstathios Kastritis
Nature Reviews. Clinical Oncology|November 28, 2009
Hematology: first-line bortezomib benefits patients with multiple myelomaMeletios A Dimopoulos, Evangelos Terpos
The American Journal of Medicine|October 7, 2004
Adverse effects of thalidomide administration in patients with neoplastic diseasesMeletios A Dimopoulos, Vagelis Eleutherakis-Papaiakovou
The Lancet. Oncology|January 6, 2018
Carfilzomib for relapsed or refractory multiple myeloma - Authors' replyMeletios A Dimopoulos, Amy S Kimball
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Reply to S. Al Hadidi et alMeletios A Dimopoulos, Jesús San-Miguel
Seminars in Hematology|April 25, 2009
Treatment of relapsed/refractory multiple myelomaEfstathios Kastritis, Antonio Palumbo, Meletios A Dimopoulos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Treatment of plasma cell dyscrasias with thalidomide and its derivativesMeletios A Dimopoulos, Athanasios Anagnostopoulos, Donna Weber
The New England Journal of Medicine|November 15, 2018
Ibrutinib and Rituximab in Waldenström's MacroglobulinemiaMeletios A Dimopoulos, Zeena Salman, Christian Buske
Advances in Chronic Kidney Disease|August 28, 2012
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspectiveEsftathios Kastritis, Meletios A Dimopoulos, Joan Bladé
Expert Opinion on Pharmacotherapy|May 28, 2013
Current treatments for renal failure due to multiple myelomaEfstathios Kastritis, Evangelos Terpos, Meletios A Dimopoulos
Pageof 74